{
    "root": "fe187ba0-468c-4a07-90b9-f8d6123673fa",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Alprazolam",
    "value": "20250515",
    "ingredients": [
        {
            "name": "ALPRAZOLAM",
            "code": "YU55MQ3IZY",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2611"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "DIETHYLHEXYL SODIUM SULFOSUCCINATE",
            "code": "F05Q2T2JA0"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_113455"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        }
    ],
    "indications": {
        "text": "alprazolam tablets indicated : \u2022acute treatment generalized anxiety disorder ( gad ) adults . \u2022treatment panic disorder ( pd ) , without agoraphobia adults .",
        "doid_entities": [
            {
                "text": "generalized anxiety disorder (DOID:14320)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_14320"
            },
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "panic disorder (DOID:594)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_594"
            },
            {
                "text": "agoraphobia (DOID:593)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_593"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 generalized anxiety disorder : ( 2.1 ) \u25cb recommended starting oral 0.25 mg 0.5 mg three times daily . \u25cb may increased , intervals every 3 4 days , maximum recommended daily dose 4 mg , given divided doses . \u25cb lowest possible effective dose frequently assess need continued treatment . \u2022 panic disorder : recommended starting oral 0.5 mg three times daily . may increased intervals every 3 4 days increments 1 mg per day . ( 2.2 ) \u2022 tapering , decrease 0.5 mg every 3 days . patients may require even slower reduction . ( 2.3 , 5.2 ) \u2022 full prescribing information recommended geriatric patients , patients hepatic impairment , ritonavir . ( 2.4 , 2.5 , 2.6 )",
        "doid_entities": [
            {
                "text": "generalized anxiety disorder (DOID:14320)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_14320"
            },
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "panic disorder (DOID:594)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_594"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "product : 50090-1864 ndc : 50090-1864-2 14 tablet bottle ndc : 50090-1864-0 30 tablet bottle product : 50090-2819 ndc : 50090-2819-1 90 tablet bottle product : 50090-2896",
    "adverseReactions": "alprazolam contraindicated patients : \u2022with known hypersensitivity alprazolam benzodiazepines . angioedema reported [ ( 6.2 ) ] . \u2022taking strong cytochrome p450 3a ( cyp3a ) inhibitors ( e.g . , ketoconazole , itraconazole ) , except ritonavir [ ( 2.6 ) , ( 5.5 ) , ( 7.1 ) ]",
    "indications_original": "Alprazolam tablets are indicated for the: \n                  \n                     \n                        \u2022acute treatment of generalized anxiety disorder (GAD) in adults. \n                     \n                        \u2022treatment of panic disorder (PD), with or without agoraphobia in adults.",
    "contraindications_original": "\u2022 Generalized Anxiety Disorder: ( 2.1 ) \u25cb Recommended starting oral dosage is 0.25 mg to 0.5 mg three times daily. \u25cb Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4 mg, given in divided doses. \u25cb Use the lowest possible effective dose and frequently assess the need for continued treatment. \u2022 Panic Disorder: Recommended starting oral dosage is 0.5 mg three times daily. The dosage may be increased at intervals of every 3 to 4 days in increments of no more than 1 mg per day. ( 2.2 ) \u2022 When tapering, decrease dosage by no more than 0.5 mg every 3 days. Some patients may require an even slower dosage reduction. ( 2.3 , 5.2 ) \u2022 See the Full Prescribing Information for the recommended dosage in geriatric patients, patients with hepatic impairment, and with use with ritonavir. ( 2.4 , 2.5 , 2.6 )",
    "warningsAndPrecautions_original": "Product:    50090-1864\n                  NDC:    50090-1864-2   14 TABLET in a BOTTLE\n                  NDC:    50090-1864-0   30 TABLET in a BOTTLE\n                  Product:    50090-2819\n                  NDC:    50090-2819-1   90 TABLET in a BOTTLE\n                  Product:    50090-2896",
    "adverseReactions_original": "Alprazolam is contraindicated in patients:\n                  \n                     \n                        \u2022with known hypersensitivity to alprazolam or other benzodiazepines. Angioedema has been reported [see Adverse Reactions (6.2)]. \n                     \n                        \u2022taking strong cytochrome P450 3A (CYP3A) inhibitors (e.g., ketoconazole, itraconazole), except ritonavir [see Dosage and Administration (2.6), Warnings and Precautions (5.5), Drug Interactions (7.1)]",
    "drug": [
        {
            "name": "Alprazolam",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2611"
        }
    ]
}